Pune, India -- (SBWire) -- 12/07/2017 --The World Gallbladder Treatment Market is growing at a healthy rate. The major players in this market are Boston Scientific Corporation, Intuitive Sur">Gallbladder Treatment Market is growing at a healthy rate. The major players in this market are Boston Scientific Corporation, Intuitive Surgical, C. R. Bard, Inc., Dornier MedTech, Koninklijke Philips N.V., B. Braun Melsungen AG, Sanofi and others. Gallbladder and biliary related diseases occurred in about 104 million people (1.6%) in 2013 and they resulted in 106,000 deaths.
The Global Gallbladder Treatment Market is expected to grow at the CAGR of 6.5% during the forecast period and is estimated to reach USD 27121.5 million by 2023. The Gall Bladder is a small pear-shaped located underneath the liver. Its main function is to store the bile produced by liver and pass it along through a duct that empties into the small intestine. Gall bladder diseases affect a large number of people in the world.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3945 .
The major driving factors for the growth of the market are increasing geriatric population, increasing prevalence rate of various gallbladder diseases, and introduction & adoption of advanced diagnostic treatment options. Moreover, increasing awareness of the diseases, rising healthcare expenditure, and rising demand from emerging markets of Asia have fuelled the market growth. However, pain and complications during surgery and asymptomatic nature of gallstones may slow the growth of the market.
Considering the global scenario of the market, North America dominates the global Gallbladder Treatment market owing to the presence of huge population suffering from gall bladder diseases. US hold the largest market share in North America Gallbladder Treatment market. In developed countries, 10–15% of adults have gallstones.
Europe has the second largest market for the Gallbladder Treatment which is followed by Asia Pacific. Presence of well-developed healthcare sector and high healthcare expenditure, the Gallbladder Treatment Industry in Europe is growing at a CAGR of 6.8%.
Asia Pacific is also witnessing a rapid growth in this market which is mainly due to rapidly increasing awareness of treatments, presence of huge population, rising healthcare expenditure and government support for research & development. Asia Pacific Gallbladder Treatment market is expected to grow at a CAGR of 7.0% during the forecasted period. The Middle East & Africa is expected to have limited growth.
Major TOC Gallbladder Treatment Market:
1 Report Prologue
2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
2.4 Market Structure
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Drivers
4.1.1 Development of minimal invasive surgical procedures
4.1.2 Rise in risk factors
4.1.3 Advancements in surgical procedures
4.2 Restraints
4.2.1 Pain and complications during surgery
4.2.2 Asymptomatic nature of gallstones
4.2.3 Excellent effectiveness and comparative cost effectiveness of surgery
4.3 Opportunities
4.3.1 Research and development
4.4 Challenges
4.4.1 High cost of cholecystectomy and robotic laparoscopy surgery
4.4.2 Stringent regulations and regulatory uncertainties in the US
4.4.3 Low public healthcare expenditure in developing regions
….Continued
Ask to Expert @ https://www.marketresearchfuture.com/enquiry/3945 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Gallbladder Treatment Market Research by MRFR Unleashing Industry Analysis and Forecasts by 2023
Global Gallbladder Treatment Market has been segmented on the basis of disease indications, diagnosis, treatment and end users. On the basis of disease indications the market is segmented as gallstones, cholecystitis & biliary colic, cholelithiasis & choledocholithiasis, gallbladder polyps and gall bladder cancer.